GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » PS Ratio

Decision Diagnostics (Decision Diagnostics) PS Ratio : 0.02 (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Decision Diagnostics's share price is $0.0001. Decision Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.01. Hence, Decision Diagnostics's PS Ratio for today is 0.02.

The historical rank and industry rank for Decision Diagnostics's PS Ratio or its related term are showing as below:

DECN's PS Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.555
* Ranked among companies with meaningful PS Ratio only.

Decision Diagnostics's Revenue per Sharefor the three months ended in Sep. 2021 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.01.

Back to Basics: PS Ratio


Decision Diagnostics PS Ratio Historical Data

The historical data trend for Decision Diagnostics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics PS Ratio Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 4.00 1.11 0.63 2.57

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.09 2.57 3.83 1.43 0.05

Competitive Comparison of Decision Diagnostics's PS Ratio

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's PS Ratio falls into.



Decision Diagnostics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Decision Diagnostics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0001/0.006
=0.02

Decision Diagnostics's Share Price of today is $0.0001.
Decision Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Decision Diagnostics  (OTCPK:DECN) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Decision Diagnostics PS Ratio Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus

DECN Comments on Recent Legal Filings by Federal Agencies

By ACCESSWIRE ACCESSWIRE 12-19-2020